DNA-PKcs could be a predictive marker of recurrence after radiotherapy in prostate cancer [28, 29], and DNA-PKcs expression may have prognostic and predictive significance in epithelial ovarian cancer [30]. This evidence concerns the gene PRKDC and prostate cancer.